FDA Inspection
InvaGen Pharmaceuticals, Inc.FDA Inspection 1302076 - InvaGen Pharmaceuticals, Inc. - February 09, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns InvaGen Pharmaceuticals, Inc., with an inspection on February 9, 2026, issued by the New York District Office, covering human drugs.
- Office
- New York District Office
Open in Dashboard
ID · 6f49afaf-f928-4ba0-a5bc-1df3f32d761d
Violation Codes2
21 CFR 211.6321 CFR 211.68(b)
Full citation text and observation details available on the Dashboard.